TAK Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

16.535

Open

16.460

VWAP

16.47

Vol

998.56K

Mkt Cap

52.00B

Low

16.420

Amount

16.44M

EV/EBITDA(TTM)

9.85

Total Shares

3.16B

12.38T

EV/OCF(TTM)

11.55

P/S(TTM)

1.84

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.

Events Timeline

(ET)

2026-05-04

08:20:00

Takeda's TAK-881 Clinical Trial Achieves Primary Endpoint

2026-04-28 (ET)

2026-04-28

09:40:00

Protagonist Therapeutics Exercises Opt-Out Right for $400 Million

2026-04-05 (ET)

2026-04-05

21:20:00

Denali Therapeutics Regains Full Control of DNL593

2026-04-01 (ET)

2026-04-01

16:20:00

Abivax Appoints Michael Nesrallah as Chief Commercial Officer

2026-04-01

07:30:00

Axsome Acquires Exclusive Global Rights to Takeda's TAK-063

News

9.5

05-04Fool

Axsome Therapeutics Shares Surge on FDA Approval and Strong Pipeline

9.0

05-01Newsfilter

FDA Approves Axsome's Auvelity for Alzheimer's Agitation

9.5

04-13stocktwits

Spyre Therapeutics' Trial Data Boosts Stock by 23%

7.5

04-03moomoo

Takeda Ends Collaboration Agreement with Denali Therapeutics on DNL593

8.5

04-03NASDAQ.COM

Biotech Landscape Update: Regulatory Approvals and Acquisitions

8.5

04-01NASDAQ.COM

Axsome Acquires Global Rights to TAK-063 from Takeda

1 Analyst Rating

Wall Street analysts forecast TAK stock price to rise

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

18.00

Averages

18.00

High

18.00

Current: 0.000

Low

18.00

Averages

18.00

High

18.00

Bernstein

Market Perform

Outperform

upgrade

AI Analysis

2026-04-08

Reason

Bernstein

Price Target

AI Analysis

2026-04-08

upgrade

Market Perform

Outperform

Reason

Bernstein upgraded Takeda to Outperform from Market Perform with a price target of 6,900 yen, up from 5,100 yen, citing \"bold\" cost cuts and multiple upcoming de-risking events for the pipeline.

H.C. Wainwright

Buy

maintain

$97

2025-12-30

Reason

H.C. Wainwright

Price Target

$97

2025-12-30

maintain

Buy

Reason

H.C. Wainwright says Xoma (XOMA) took "a nice ride down the creativity road again with nice pipeline expansion," after the company announced an expanded relationship with partner Takeda (TAK). The deal with Takeda is highlighted by no cash out from Xoma for bringing in nine assets, the firm notes. This was accomplished by only marginally reducing Xoma's royalty/milestone share in Takeda's mezagitamab. Wainwright maintains its positive view here on the depth and breadth of Xoma's partnered assets as well as the ongoing creativity of transaction the company consummates, and looks forward to a transactional and royalty growing 2026. The firm has a Buy rating on Xoma with a price target of $97 on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TAK

Unlock Now

Valuation Metrics

The current forward P/E ratio for Takeda Pharmaceutical Co Ltd (TAK.N) is 10.50, compared to its 5-year average forward P/E of 26.59. For a more detailed relative valuation and DCF analysis to assess Takeda Pharmaceutical Co Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

26.59

Current PE

10.50

Overvalued PE

39.84

Undervalued PE

13.33

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

8.96

Current EV/EBITDA

3.41

Overvalued EV/EBITDA

10.93

Undervalued EV/EBITDA

6.99

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.45

Current PS

0.01

Overvalued PS

1.87

Undervalued PS

1.04

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

top value stocks

Intellectia · 85 candidates

Market Cap Category: large, midCurrent Ratio: >= 1.00Pe Ttm: <= 15Ps Ratio: <= 3.00P/B Ratio: <= 3.00Return On Equity: >= 0.0%P Fcf Ratio: <= 15.00Free Cash Flow Ttm: >= 0

Ticker

Name

Market Cap$

BILL

BILL Holdings Inc

4.14B

CALY

Callaway Golf Co

3.19B

AXIA

Axia Energia SA

26.97B

Ecopetrol SA

25.99B

KT Corp

10.20B

TGS

Transportadora de Gas del Sur SA

4.42B

top investment for cheap buy

Intellectia · 208 candidates

Market Cap: >= 300.00MPrice: <= $20.00Analyst Consensus: Moderate Buy, Strong BuyEps Ttm: >= 0Free Cash Flow Ttm: >= 0

Ticker

Name

Market Cap$

SONY

Sony Group Corp

116.85B

ITUB

Itau Unibanco Holding SA

95.00B

NOK

Nokia Oyj

74.38B

Energy Transfer LP

68.60B

TAK

Takeda Pharmaceutical Co Ltd

52.51B

HBAN

Huntington Bancshares Inc

33.71B

fang

Intellectia · 1 candidates

Region: US

Ticker

Name

Market Cap$

TAK

Takeda Pharmaceutical Co Ltd

52.51B

insiders buying stocks

Intellectia · 1172 candidates

Market Cap: >= 1000.00MPrice: >= $5.00Quarterly Insider Trading Dollar Volume: >= 0Monthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

TAK

Takeda Pharmaceutical Co Ltd

56.30B

KSPI

Kaspi.kz AO

15.10B

CEPU

Central Puerto SA

2.42B

Royal Bank of Canada

242.44B

Bank of New York Mellon Corp

88.88B

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.92T

large cap taht is basing

Intellectia · 14 candidates

Market Cap: >= 10.00BRsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA200Month Price Change Pct: $-5.00 - $5.00Support Resistance Relationship: PriceAroundSupport

Ticker

Name

Market Cap$

JNJ

Johnson & Johnson

574.36B

AMGN

Amgen Inc

189.44B

PFE

Pfizer Inc

153.13B

WMB

Williams Companies Inc

88.95B

WBD

Warner Bros Discovery Inc

68.79B

TAK

Takeda Pharmaceutical Co Ltd

57.12B

what stocks to buy today by swing max

Intellectia · 30 candidates

Region: USPrice: $5.00 - $150.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20One Week Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

BFAM

Bright Horizons Family Solutions Inc

4.21B

GLRE

Greenlight Capital Re Ltd

563.79M

RILY

BRC Group Holdings Inc

214.47M

BOX

Box Inc

3.37B

FTS

Fortis Inc

29.71B

NTES

NetEase Inc

75.69B

ANY STOCK FROM 5 TO 20.00

Intellectia · 1059 candidates

Region: USPrice: $5.00 - $20.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

MUFG

Mitsubishi UFJ Financial Group Inc

202.67B

SAN

Banco Santander SA

185.79B

MFG

Mizuho Financial Group Inc

105.35B

PBR

Petroleo Brasileiro SA Petrobras

92.03B

ITUB

Itau Unibanco Holding SA

91.41B

Nu Holdings Ltd

87.41B

us stock between $0.1 and $20

Intellectia · 2503 candidates

Price: $0.10 - $20.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

MUFG

Mitsubishi UFJ Financial Group Inc

206.98B

SAN

Banco Santander SA

178.90B

MFG

Mizuho Financial Group Inc

104.37B

PBR

Petroleo Brasileiro SA Petrobras

87.06B

ITUB

Itau Unibanco Holding SA

86.67B

Nu Holdings Ltd

83.54B

show stock below $20 and are marked bullish

Intellectia · 1002 candidates

Price: <= $20.00Option Sentiments: Bullish

Ticker

Name

Market Cap$

LYG

Lloyds Banking Group PLC

81.38B

Energy Transfer LP

60.60B

TAK

Takeda Pharmaceutical Co Ltd

51.17B

BSBR

Banco Santander Brasil SA

50.00B

ASX

ASE Technology Holding Co Ltd

41.24B

NOK

Nokia Oyj

35.71B

acciones por debajo 20 dolares

Intellectia · 3008 candidates

Price: <= $20.00

Ticker

Name

Market Cap$

MUFG

Mitsubishi UFJ Financial Group Inc

206.98B

SAN

Banco Santander SA

178.90B

MFG

Mizuho Financial Group Inc

104.37B

PBR

Petroleo Brasileiro SA Petrobras

87.06B

ITUB

Itau Unibanco Holding SA

86.67B

Nu Holdings Ltd

83.54B

Whales Holding TAK

Trading Trends

People Also Watch

Frequently Asked Questions

What is Takeda Pharmaceutical Co Ltd (TAK) stock price today?

The current price of TAK is 16.445 USD — it has decreased -0.09

What is Takeda Pharmaceutical Co Ltd (TAK)'s business?

What is the price predicton of TAK Stock?

Wall Street analysts forecast TAK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TAK is18.00 USD with a low forecast of 18.00 USD and a high forecast of 18.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Takeda Pharmaceutical Co Ltd (TAK)'s revenue for the last quarter?

Takeda Pharmaceutical Co Ltd revenue for the last quarter amounts to 1.19T USD, increased 4.16

What is Takeda Pharmaceutical Co Ltd (TAK)'s earnings per share (EPS) for the last quarter?

Takeda Pharmaceutical Co Ltd. EPS for the last quarter amounts to 65.65 USD, increased 337.08

How many employees does Takeda Pharmaceutical Co Ltd (TAK). have?

Takeda Pharmaceutical Co Ltd (TAK) has 47455 emplpoyees as of May 11 2026.

What is Takeda Pharmaceutical Co Ltd (TAK) market cap?

Today TAK has the market capitalization of 52.00B USD.

TAK Overview

TAK Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding TAK

Trading Trends

People Also Watch

Frequently Asked Questions

What is Takeda Pharmaceutical Co Ltd (TAK) stock price today?

What is Takeda Pharmaceutical Co Ltd (TAK)'s business?

What is the price predicton of TAK Stock?

What is Takeda Pharmaceutical Co Ltd (TAK)'s revenue for the last quarter?

What is Takeda Pharmaceutical Co Ltd (TAK)'s earnings per share (EPS) for the last quarter?

How many employees does Takeda Pharmaceutical Co Ltd (TAK). have?

What is Takeda Pharmaceutical Co Ltd (TAK) market cap?